A. Taylor

发表

Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.

E. van Cauter, E. Cauter, M. Thorner, 1996, The Journal of clinical endocrinology and metabolism.

A double-blind, parallel-group, placebo-controlled, dose-ranging, multicenter study of intravenous granisetron in the treatment of postoperative nausea and vomiting in patients undergoing surgery with general anesthesia.

P. Diemunsch, Ann M. Taylor, D. Thorin, 1997, Journal of clinical anesthesia.

Human plasma fractions inhibit the action of insulin on adipocytes and somatomedin on cartilage

P. Dandona, A. Taylor, M. Khokher, 1986, Diabetologia.

Menstrual Irregularities are more Common in Adolescents with Type 1 Diabetes: Association with Poor Glycaemic Control and Weight Gain

D. Dunger, A. Taylor, J. Jones, 1994, Diabetic medicine : a journal of the British Diabetic Association.

Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins.

R. Valcavi, R. Ross, H. Maheshwari, 1993, The Journal of clinical endocrinology and metabolism.

A monoclonal antibody to human insulin-like growth factor-I: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor.

M. Preece, H. Dadi, A. Taylor, 1989, Journal of molecular endocrinology.

THE GROWTH HORMONE INDEPENDENT INSULIN‐LIKE GROWTH FACTOR‐I BINDING PROTEIN BP‐28 IS ASSOCIATED WITH SERUM INSULIN‐LIKE GROWTH FACTOR‐I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN‐DEPENDENT DIABETICS

D. Dunger, M. Preece, J. Wass, 1990, Clinical endocrinology.

Impact of Increased Growth Hormone Secretion on Carbohydrate Metabolism in Adolescents with Diabetes

D. Dunger, J. Edge, D. Matthews, 1991, Acta paediatrica Scandinavica. Supplement.

Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma.

R. Carey, A. Taylor, A. Johanson, 1975, The New England journal of medicine.

The effects of recombinant human insulin‐like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus

D. Dunger, D. Matthews, J. Holly, 1994, Clinical endocrinology.

Loss of the normal relationships between growth hormone, growth hormone‐binding protein and insulin‐like growth factor‐I in adolescents with insulin‐dependent diabetes mellitus

D. Dunger, Jenny Jones, L. Carlsson, 1994, Clinical endocrinology.

Disposition and pharmacokinetics of [14C]finasteride after oral administration in humans.

P. Höglund, K. Andersson, A. Taylor, 1992, Drug metabolism and disposition: the biological fate of chemicals.

Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis

D. Dunger, A. Bush, J. Holly, 1997, Archives of disease in childhood.

A selective inhibitor of cyclooxygenase-2 reverses endotoxin-induced pyretic responses in non-human primates.

I. Rodger, C. Chan, A. Taylor, 1997, European journal of pharmacology.

Phosphodiesterase inhibition improves agonist-induced relaxation of hypertensive pulmonary arteries.

A. Taylor, R. Rhoades, C. Smith, 1997, The Journal of pharmacology and experimental therapeutics.

Actions of insecticides on the insect GABA receptor complex.

I. Bermúdez, A. Taylor, C. Hawkins, 1991, Journal of receptor research.

The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with Type 1 (insulin-dependent) diabetes mellitus

D. Dunger, D. Matthews, J. Holly, 1993, Diabetologia.

Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls.

D. Dunger, M. Preece, D. Grant, 1988, Diabetes research.

Inhibition of somatomedin-like activity by serum from streptozotocin-diabetic rats: prevention by insulin treatment and correlation with skeletal growth.

P. Thomas, P. Dandona, A. Sharma, 1987, Endocrinology.

The Endocrinology of Male Puberty

D. Dunger, N. Cameron, M. Preece, 1984 .

The relationship between insulin, IGF‐I and weight gain in cystic fibrosis

D. Dunger, J. Holly, D. Dunger, 1999, Clinical endocrinology.

The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers.

F. Pralong, J. Holly, R. Ross, 1993, The Journal of endocrinology.

The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.

D. Dunger, R. Baxter, J. Holly, 1998, The Journal of endocrinology.

P. Dandona, A. Taylor, M. Khokher, 1986, Diabetes research (Edinburgh, Scotland).

BIGUANIDES INHIBIT SOMATOMEDIN ACTION IN VITRO

P. Dandona, A. Taylor, M. Khokher, 1983 .

MACROSOMIA DESPITE WELL-CONTROLLED DIABETIC PREGNANCY

P. Dandona, D. Freedman, H. Besterman, 1984, The Lancet.

Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life.

D. Dunger, M. Preece, M. Savage, 1989, The Journal of clinical endocrinology and metabolism.

The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.

M. Preece, J. Holly, J. Wass, 1992, The Journal of clinical endocrinology and metabolism.

Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight/body weight change during abnormal thyroid function?

R. Ross, D. Jewitt, A. Taylor, 1993, Journal of molecular endocrinology.

The kindling model of alcohol dependence: similar persistent reduction in seizure threshold to pentylenetetrazol in animals receiving chronic ethanol or chronic pentylenetetrazol.

R. Olsen, A. Taylor, D. W. Sapp, 1993, Alcoholism, clinical and experimental research.

Purification of insulin-like growth factor I

M. Preece, A. Taylor, D. Morrell, 1984, Regulatory Peptides.

Somatomedin C/insulin-like growth factor I: simplified purification procedure and biological activities of the purified growth factor.

M. Preece, D. Hill, K. Ray, 1986, The Journal of endocrinology.

Insulin like growth factor‐I, protein kinase‐C, calcium and cyclic AMP: Partners in the regulation of chondrocyte mitogenesis and metabolism

M. Preece, P. Dandona, M A Preece, 1988, FEBS letters.

Effect of metformin on insulin receptor binding and diabetic control.

P. Dandona, A. Taylor, R. J. Woods, 1983, British medical journal.

INSULIN-RECEPTOR ANTIBODY AND HYPOGLYCAEMIA ASSOCIATED WITH HODGKIN'S DISEASE

R. Denton, J. Tavaré, P. Dandona, 1987, The Lancet.